Replies to post #1417 on Cytokinetics, Inc. (CYTK)

[H2R]

And the SA author's reply to a comment from "Andre":

Author’s reply » Andre,
I didn't mean to leave an impression that it would be 2020 before we would see any appreciation in the stock. My point was an investor could dollar cost average in the interim so as we approach this date we should have a health position in the stock--and what I think will be major catalyst to support the higher price. As stated in my article, I own the stock, with plans to add during this interim period.

[...]

With that said---we are hitting a level where we should see some profit taking...which will be good as we need to consolidate the upward movement, before we can see the next leg up. So investors should wait to add or start their position---IMO! And just for the record--I will hold as I have the 2020 date for my binary catalyst. However, I will hold waiting for a better entry new funds being applied. I might also add, with the caveat that investing in a stock strictly because of a buy-out is not a good reason to base your decision. With that said----Amgen might decide they prefer not to pay milestones and double digit royalties to CYTK---just think!!!
Good luck with your future investing decisions!